Omnicell beat analysts’ revenue expectations by 2.2% last quarter, reporting revenues of $306.9 million, up 18.6% year on year. It was a slower quarter for the company, with EBITDA guidance for ...

Omnicell, Inc.'s (NASDAQ:OMCL) earnings announcement last week was disappointing for investors, despite the decent profit numbers. We did some digging and actually think they are being ...

Shares of healthcare tech company Omnicell (NASDAQ:OMCL) fell 17.5% in the afternoon session after the company reported weak first-quarter 2025 results, which featured full-year EPS and EBITDA ...

CEO Randall Lipps highlighted strong Q1 2025 performance driven by demand for Omnicell's medication management platform. Key focus areas included market share growth in inpatient and outpatient ...

Wells Fargo upgraded Omnicell (NASDAQ:OMCL) to Overweight from Equal Weight on Wednesday, citing a compelling risk-reward setup in the shares of the Fort Worth, Texas-based vendor of pharmacy ...

AUSTIN, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery ...

Ratings for Omnicell (NASDAQ:OMCL) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings ...

FORT WORTH, Texas - Omnicell, Inc. (NASDAQ:OMCL), a $1.35 billion market cap healthcare technology company known for its pharmacy and nursing care solutions, has introduced a new line of products ...

FORT WORTH, Texas (AP) — FORT WORTH, Texas (AP) — Omnicell Inc. (OMCL) on Tuesday reported a loss of $7 million in its first quarter. On a per-share basis, the Fort Worth, Texas-based company ...

Omnicell shares fell after the company lowered its guidance due to expected costs and uncertainty from tariffs. The stock slid 15% to $26.01 on Tuesday morning, at one point touching a 52-week low ...